Cardiovascular Disease Clinical Trial
Official title:
The Impact of Age and Fitness on Endothelial Reperfusion Injury and the Ability of Ischemic Preconditioning to Prevent This Injury
Rationale: Ischaemic preconditioning (IP) refers to the reduction of ischemia-reperfusion
injury induced by a brief preceding period of ischemia. Also the arterial endothelium can be
protected by IP. Several studies performed in animals and humans have demonstrated that the
protective effects of IP are attenuated with aging. However, no previous study directly
examined the underlying mechanisms of this observation. Possibly, the reduced protective
effect of IP with aging relates to a direct effect on the endothelium, consequently leading
to an attenuated ability of IP to prevent endothelial dysfunction after ischaemia
reperfusion injury.
Several previous studies failed to demonstrate the ability of pharmacological stimuli to
mimic the beneficial effects of IP in aged vessels. Restoration of the age-related reduction
in effectiveness of IP may be possible through exercise training. In aged animals, physical
training restores the efficacy of ischemic preconditioning. Indirect evidence indicates that
physical activity, independent of other cardiovascular risk factors, protects against a
occurrence as well as the severity of a myocardial infarction in humans. Although this
suggests that physical activity may beneficially influence the age-related reduction in IP,
no previous study provided direct evidence for this hypothesis.
Objective: To examine the impact of age and physical fitness on the ability of ischaemic
preconditioning to protect endothelial damage in response to ischaemia reperfusion injury in
healthy humans. A secondary objective is to explore the role of Toll-like receptor (TLR)
signalling in the induction of IP in young and old subjects.
Cardiovascular disease has become a worldwide burden. In the Netherlands over 40.000 persons
die annually due to coronary artery disease, either acute myocardial infarction or heart
failure.1 Through plaque formation and negative vascular remodelling, significant stenotic
lesions develop in the coronary arteries that subsequently limit coronary blood flow and
ultimately can cause ischemic events. Reperfusion therapy (either pharmacologic,
endovascular or surgical) is mandatory for salvage of ischemic tissue. However, during
reperfusion several deleterious events take place causing further damage. Murry found that
ischemia and reperfusion injury (IR-injury) could be reduced by a phenomenon called ischemic
preconditioning.2 Short lasting repetitive episodes of ischemia prior to an ischemic event
can induce tissue tolerance against IR-injury.
After discovery of this phenomenon, ample research has been devoted to elucidation of the
underling protective mechanism, but also factors that improve or impair the ability of this
phenomenon to protect arteries against ischaemia reperfusion injury. Several studies
performed in animals and humans have demonstrated that the protective effects of IP are
attenuated with aging. Much of this work has been performed in animal models or in human in
vitro studies. Interestingly, no previous study directly examined the underlying mechanisms
of this observation in humans using in vivo techniques. One potential explanation for an
age-related reduction of the protective effect of IP relates to a direct effect on the
endothelium.
Much scientific effort has been devoted to develop a human in vivo model to study ischemia
and reperfusion injury. Recently, publications emerged using the flow mediated dilation
(FMD) of the brachial or radial artery before and after a sustained ischaemic stimulus (20
minutes) to establish the presence of a blunted endothelial function after ischaemia
reperfusion injury.3, 4 This effect of reperfusion injury on the endothelial function can be
abrogated by ischemic preconditioning.3 Endothelial dysfunction is acknowledged to be the
first (subclinical) manifestation of atherosclerosis and cardiovascular disease.5, 6 It is
significantly correlated to occurrence of myocardial infarction and stroke.6 Assessment of
the flow mediated dilation of the brachial artery as measure of endothelial (dys)function,
is a validated model to research effects of possible protective strategies3, 4 and perform
mechanistic experiments4, 7, 8 on IR-injury in humans in vivo.
Several previous studies failed to demonstrate the ability of pharmacological stimuli to
mimic the beneficial effects of IP in aging vessels.9 Restoration of the age-related
reduction in effectiveness of IP may be possible through exercise training. Indirect
evidence indicates that physical activity, independent of other cardiovascular risk factors,
protects against an occurrence as well as the severity of a myocardial infarction in
humans.10 Although this suggests that physical activity may beneficially influence the
age-related reduction in IP, no previous study provided direct evidence for this hypothesis
in humans.
In this cross-sectional observational experiment we will study the impact of aging (young
versus older subjects) and physical fitness (sedentary versus trained older subjects) on the
protective effects of ischaemic preconditioning on brachial artery endothelial function
after ischaemia-reperfusion injury in healthy humans in vivo.
We hypothesize that aging is associated with an attenuated ability of ischaemic
preconditioning to prevent the decrease in brachial artery endothelial function observed
after ischaemia reperfusion injury. Moreover, we expect that the age-related reduction in
effectiveness of ischaemic preconditioning to prevent endothelial dysfunction after
reperfusion injury is (at least partly) preserved in trained older subjects.
;
Observational Model: Cohort, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT02502812 -
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04216342 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03654313 -
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
|
Phase 1 | |
Completed |
NCT03646656 -
Heart Health Buddies: Peer Support to Decrease CVD Risk
|
N/A | |
Completed |
NCT02081066 -
Identification of CETP as a Marker of Atherosclerosis
|
N/A | |
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
Recruiting |
NCT03095261 -
Incentives in Cardiac Rehabilitation
|
N/A | |
Completed |
NCT02998918 -
Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
|
N/A | |
Not yet recruiting |
NCT02578355 -
National Plaque Registry and Database
|
N/A | |
Completed |
NCT02711878 -
Healing Hearts and Mending Minds in Older Adults Living With HIV
|
N/A | |
Completed |
NCT02589769 -
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
|
N/A | |
Completed |
NCT02868710 -
Individual Variability to Aerobic Exercise Training
|
N/A | |
Recruiting |
NCT02885792 -
Coronary Artery Disease in Patients Suffering From Schizophrenia
|
N/A | |
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Completed |
NCT02640859 -
Investigation of Metabolic Risk in Korean Adults
|
||
Completed |
NCT02657382 -
Mental Stress Ischemia: Biofeedback Study
|
N/A | |
Completed |
NCT02272946 -
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
|
Phase 2 | |
Recruiting |
NCT02265250 -
Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
|